TY - JOUR
AU1 - Bornstein, Robert A.
AB - ORIGINAL ARTICLE Self-administered Gerocognitive Examination (SAGE) A Brief Cognitive Assessment Instrument for Mild Cognitive Impairment (MCI) and Early Dementia Douglas W. Scharre, MD,* Shu-Ing Chang, PharmD,* Robert A. Murden, MD,w James Lamb, MD,w David Q. Beversdorf, MD,*z Maria Kataki, MD, PhD,* Haikady N. Nagaraja, PhD,y and Robert A. Bornstein, PhDJ Conclusions: This study suggests that SAGE is a reliable instrument Objectives: To develop a self-administered cognitive assessment for detecting cognitive impairment and compares favorably with instrument to facilitate the screening of mild cognitive impairment the MMSE. The self-administered feature may promote cogni- (MCI) and early dementia and determine its association with tive testing by busy clinicians prompting earlier diagnosis and gold standard clinical assessments including neuropsychologic treatment. evaluation. Key Words: self-administered, cognitive screen, mild cognitive Methods: Adults aged above 59 years with sufficient vision and impairment, early dementia English literacy were recruited from geriatric and memory disorder (Alzheimer Dis Assoc Disord 2010;24:64–71) clinics, educational talks, independent living facilities, senior centers, and memory screens. After Self-administered Gerocogni- tive Examination (SAGE) screening, subjects were randomly selected to complete a clinical evaluation, neurologic examination, neuropsychologic battery, functional assessment, and mini-mental he number of individuals projected to have Alzheimer state examination (MMSE). Subjects 
TI - Self-administered Gerocognitive Examination (SAGE) A Brief Cognitive Assessment Instrument for Mild Cognitive Impairment (MCI) and Early Dementia
JF - Alzheimer Disease & Associated Disorders
DO - 10.1097/WAD.0b013e3181b03277
DA - 2010-01-01
UR - https://www.deepdyve.com/lp/wolters-kluwer-health/self-administered-gerocognitive-examination-sage-a-brief-cognitive-uconaYN0Y0
SP - 64
EP - 71
VL - 24
IS - 1
DP - DeepDyve
ER -